Phillip B. Donenberg is of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 163,331 shares of TSHA, which is worth approximately $338,095. The most recent transaction as insider was on May 29, 2024, when has been sold 49,220 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 163K
0% 3M change
43.13% 12M change
Total Value Held $338,095

Phillip B. Donenberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2024
BUY
Grant, award, or other acquisition
-
49,220 Added 23.16%
163,331 Common Stock
Aug 16 2023
BUY
Open market or private purchase
$99,999 $0.9 p/Share
111,111 Added 49.33%
114,111 Common Stock
Feb 02 2022
BUY
Open market or private purchase
$23,340 $7.78 p/Share
3,000 Added 50.0%
3,000 Common Stock

Also insider at

AVRO
AVROBIO, Inc. Healthcare
PBD

Phillip B. Donenberg

Cambridge, MA

Track Institutional and Insider Activities on TSHA

Follow Taysha Gene Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TSHA shares.

Notify only if

Insider Trading

Get notified when an Taysha Gene Therapies, Inc. insider buys or sells TSHA shares.

Notify only if

News

Receive news related to Taysha Gene Therapies, Inc.

Track Activities on TSHA